PMID- 31358062 OWN - NLM STAT- MEDLINE DCOM- 20200625 LR - 20200625 IS - 1757-6512 (Electronic) IS - 1757-6512 (Linking) VI - 10 IP - 1 DP - 2019 Jul 29 TI - Long noncoding RNA CCDC144NL-AS1 knockdown induces naive-like state conversion of human pluripotent stem cells. PG - 220 LID - 10.1186/s13287-019-1323-9 [doi] LID - 220 AB - BACKGROUND: Human naive pluripotency state cells can be derived from direct isolation of inner cell mass or primed-to-naive resetting of human embryonic stem cells (hESCs) through different combinations of transcription factors, small molecular inhibitors, and growth factors. Long noncoding RNAs (lncRNAs) have been identified to be crucial in diverse biological processes, including pluripotency regulatory circuit of mouse pluripotent stem cells (PSCs), but few are involved in human PSCs' regulation of pluripotency and naive pluripotency derivation. This study initially planned to discover more lncRNAs possibly playing significant roles in the regulation of human PSCs' pluripotency, but accidently identified a lncRNA whose knockdown in human PSCs induced naive-like pluripotency conversion. METHODS: Candidate lncRNAs tightly correlated with human pluripotency were screened from 55 RNA-seq data containing human ESC, human induced pluripotent stem cell (iPSC), and somatic tissue samples. Then loss-of-function experiments in human PSCs were performed to investigate the function of these candidate lncRNAs. The naive-like pluripotency conversion caused by CCDC144NL-AS1 knockdown (KD) was characterized by quantitative real-time PCR, immunofluorescence staining, western blotting, differentiation of hESCs in vitro and in vivo, RNA-seq, and chromatin immunoprecipitation. Finally, the signaling pathways in CCDC144NL-AS1-KD human PSCs were examined through western blotting and analysis of RNA-seq data. RESULTS: The results indicated that knockdown of CCDC144NL-AS1 induces naive-like state conversion of human PSCs in the absence of additional transcription factors or small molecular inhibitors. CCDC144NL-AS1-KD human PSCs reveal naive-like pluripotency features, such as elevated expression of naive pluripotency-associated genes, increased developmental capacity, analogous transcriptional profiles to human naive PSCs, and global reduction of repressive chromatin modification marks. Furthermore, CCDC144NL-AS1-KD human PSCs display inhibition of MAPK (ERK), accumulation of active beta-catenin, and upregulation of some LIF/STAT3 target genes, and all of these are concordant with previously reported traits of human naive PSCs. CONCLUSIONS: Our study unveils an unexpected role of a lncRNA, CCDC144NL-AS1, in the naive-like state conversion of human PSCs, providing a new perspective to further understand the regulation process of human early pluripotency states conversion. It is suggested that CCDC144NL-AS1 can be potentially valuable for future research on deriving higher quality naive state human PSCs and promoting their therapeutic applications. FAU - Wang, Yingying AU - Wang Y AD - Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. FAU - Guo, Baosen AU - Guo B AD - College of Life Sciences, Nanchang University, Nanchang, 330031, China. FAU - Xiao, Zengrong AU - Xiao Z AD - College of Life Sciences, Nanchang University, Nanchang, 330031, China. FAU - Lin, Haijun AU - Lin H AD - College of Life Sciences, Nanchang University, Nanchang, 330031, China. FAU - Zhang, Xi AU - Zhang X AD - Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. FAU - Song, Yueqiang AU - Song Y AD - Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. FAU - Li, Yalei AU - Li Y AD - College of Life Sciences, Nanchang University, Nanchang, 330031, China. FAU - Gao, Xuehu AU - Gao X AD - College of Life Sciences, Nanchang University, Nanchang, 330031, China. FAU - Yu, Jinjun AU - Yu J AD - College of Life Sciences, Nanchang University, Nanchang, 330031, China. FAU - Shao, Zhihua AU - Shao Z AD - Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. FAU - Li, Xuekun AU - Li X AD - The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310052, China. FAU - Luo, Yuping AU - Luo Y AD - Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. luoyuping@163.com. AD - Human Aging Research Institute and School of Life Science, Nanchang University, Nanchang, 330031, China. luoyuping@163.com. FAU - Li, Siguang AU - Li S AUID- ORCID: 0000-0002-1740-2060 AD - Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. siguangli@163.com. AD - Collaborative Innovation Center for Brain Science, Tongji University, Shanghai, 200092, China. siguangli@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190729 PL - England TA - Stem Cell Res Ther JT - Stem cell research & therapy JID - 101527581 RN - 0 (RNA, Long Noncoding) RN - 0 (RNA, Small Interfering) RN - 0 (STAT3 Transcription Factor) RN - 0 (STAT3 protein, human) RN - 0 (Transcription Factors) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Cell Line MH - Cluster Analysis MH - Down-Regulation MH - Extracellular Signal-Regulated MAP Kinases/genetics/metabolism MH - Human Embryonic Stem Cells/cytology/metabolism MH - Humans MH - Karyotype MH - Pluripotent Stem Cells/cytology/metabolism MH - RNA Interference MH - RNA, Long Noncoding/antagonists & inhibitors/genetics/*metabolism MH - RNA, Small Interfering/metabolism MH - STAT3 Transcription Factor/genetics/metabolism MH - Signal Transduction MH - Transcription Factors/genetics/metabolism MH - Transcriptome PMC - PMC6664583 OTO - NOTNLM OT - Human PSCs OT - Human naive pluripotency OT - MAPK/ERK signaling pathway OT - Wnt signaling pathway OT - lncRNA COIS- The authors declare that they have no competing interests. EDAT- 2019/07/31 06:00 MHDA- 2020/06/26 06:00 PMCR- 2019/07/29 CRDT- 2019/07/31 06:00 PHST- 2019/02/17 00:00 [received] PHST- 2019/07/02 00:00 [accepted] PHST- 2019/06/18 00:00 [revised] PHST- 2019/07/31 06:00 [entrez] PHST- 2019/07/31 06:00 [pubmed] PHST- 2020/06/26 06:00 [medline] PHST- 2019/07/29 00:00 [pmc-release] AID - 10.1186/s13287-019-1323-9 [pii] AID - 1323 [pii] AID - 10.1186/s13287-019-1323-9 [doi] PST - epublish SO - Stem Cell Res Ther. 2019 Jul 29;10(1):220. doi: 10.1186/s13287-019-1323-9.